China Secures 100 Million Doses of BioNTech Vaccine

[CAPRICORN-88]

Does this look like Fosun official website to you?

https://investors.biontech.de/node/8801/pdf

BTW nobody's talking about Ip ,since Fosun invested in BioNtech,not the other way around,BioNtech is likely the parent here,but contrary to what you tried to insinuate,Fosun invested 135 million + in the development of vac ,and obtained 1,580,777 equity shares , the agreement makes it clear that fosun will get 70-61 % of profit from BioNtech vaccines ever sold to CHINA,Taiwan,HK,Macau. That is, if Chinese Health Ministry even allows the Mrna vac in china,which haven't happened yet.

Well. All these are academic.
China has announced that they will produced 2 billion doses of vaccines by the end of 2021 and based on what I hearing from Indians in here, India will be producing at least 2X or 3X more than that of China.
Well. We will wait for the result by Q1 or H1 2021.

 

[JSCh]

https://twitter.com/x/status/1353925129416421376

 

[JSCh]

https://twitter.com/x/status/1354044315836719105

 

[Srinivas]

Wow...chinese cover up for their vaccine failure in display here.

 

[Globenim]

lol bitter Indian and American liars digging out month old articles about almost a year old advance agreements and partnerships to cope with bad news pouring trough the propaganda for their hail mary vaccines that Western media struggles to contain with rethoric and distracting lies about competing vaccines "failures" that are doing just as good and better.

I guess they are reaching their wits end.

 

[KhanBaba2]

Chinese health experts advise Australia to halt approval for Pfizer vaccine following Norwegian deaths

Countries like Australia, which is expected to soon give the green light to Pfizer-BioNTech's COVID-19 vaccine for use in elderly people, need to suspend their approval procedures to wait for the World Health Organization (WHO) and Norway to investigate deaths in Norway, Chinese health experts...

defence.pk

 

[Beast]

Wow...chinese cover up for their vaccine failure in display here.

While Indian elite try to cover up modi covid-19 failed handling with plenty of self bragging poll claiming many Indian are happy with modi management.

There are still plenty of Indian farmers protesting against modi. Talk about self delusion. Nobody can beat Indians.

 

[JSCh]

Instead of playing politic and perception distorting propaganda game, protecting the life of Chinese people is more important. China would invest in various technology, such that China would have more options when there is a need for vaccination.

There is another technology for vaccine that is different from mRNA, the DNA vaccine.

Back in January 30, 2020, when Wuhan is in lockdown,

https://www.facebook.com/INOVIOPharmaceuticals/posts/972699013113708

Press release from January 4, 2021,

​

PLYMOUTH MEETING, Pa. and SUZHOU, China, Jan. 4, 2021 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, and Advaccine Biopharmaceuticals Suzhou Co., Ltd. ("Advaccine"), an emerging biotech company with next-generation technology in vaccines, both preventive and therapeutic, today announced that they have entered into a collaboration and license agreement for COVID-19 DNA vaccine candidate INO-4800.​

​

Under the collaboration and license agreement, Advaccine will have the exclusive right to develop, manufacture and commercialize INO-4800 within Greater China, inclusive of Mainland China, Hong Kong, Macao, and Taiwan. Advaccine will license its plasmid manufacturing process for use with INO-4800 and other INOVIO pipeline product candidates to INOVIO with the right to sublicense to INOVIO's manufacturing partners. Additionally, Advaccine will provide its clinical data to INOVIO in support of INOVIO's global INO-4800 regulatory filings and INOVIO will provide its INO-4800 clinical data for Advaccine to incorporate into its marketing applications in Greater China. Advaccine will make to INOVIO an upfront payment of $3.0 million as well as pay an aggregate of $108.0 million upon the achievement of specified development and sales-based milestones for INO-4800 in Greater China. INOVIO will be entitled to receive a royalty equal to a high single-digit percentage of annual net sales in each region within Greater China.​

​

....​

INOVIO and Advaccine Announce Exclusive Partnership To Commercialize COVID-19 DNA Vaccine Candidate, INO-4800, in Greater China

/PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from...

www.prnewswire.com